Rebecca Garnham Dr Daniel Geh Ryan Nelson Erik Ramon Gil Laura Wilson et al. | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2024 |
|
Dr Jack Leslie Dr Jill Hunter Amy Collins Amelia Rushton Lauren Russell et al. | c-Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis | 2023 |
|
Rebecca Garnham Dr Daniel Geh Ryan Nelson Erik Ramon Gil Laura Wilson et al. | ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2023 |
|
Dr Daniel Geh Robyn Watson Gourab Sen Jeremy French John Hammond et al. | COVID-19 and liver cancer: Lost patients and larger tumours | 2022 |
|
Dr Jack Leslie Erik Ramon Gil Kathryn Gilroy Dr Saimir Luli Maja Laszczewska et al. | CXCR2 inhibition enables NASH-HCC immunotherapy | 2022 |
|
Dr Daniel Geh Dr Jack Leslie Professor Helen Reeves Professor Derek Mann
| Neutrophils as potential therapeutic targets in hepatocellular carcinoma | 2022 |
|
Dr Marco Zaki Dr Sari Alhasan Dr Ruchi Shukla Misti McCain Maja Laszczewska et al. | Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma? | 2022 |
|